card-3216_Biochemistry expert scientific with eyeglasses
Digital innovation

Driving operational improvements and quality of our services

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3242_Scientist using tablet while colleagues working behind
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate
Corporate Video

Our commitment to customer success is embedded in every facet of our operations.

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3216_Biochemistry expert scientific with eyeglasses
Digital Innovation

Driving operational improvements and quality of our services

Learn more
English You are about to exit for another IQVIA country or region specific website Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. Ok Open in new tab Search
card-13012-0030-patient-doctor-nurse-man-woman

Therapeutic Expertise

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Empowering better patient outcomes

Aiming to reach patients with viable treatment options quicker while upholding safety and quality standards, clinical trial sponsors should be able to rely on the therapeutic expertise, solutions, and capabilities from all partners, including lab service providers, to ensure success.
 
Leveraging our global lab network, IQVIA Laboratories provides a holistic approach to meet your individual needs per therapeutic area of interest. Understanding every therapeutic focus can have unique challenges and needs, the experienced team of scientific and lab experts create innovative approaches using our comprehensive suite of complex lab testing and assessment solutions per therapeutic focus and related nuances and where you are in your development journey. Whether meeting regulatory submissions or supporting proof of mechanism and safety and efficacy evaluations, the expert team aims to support your goals to improve patient outcomes per disease with diverse yet interconnected transformative capabilities.

Explore our therapeutic and specialty areas

Click each area to learn more

Excellence by Therapeutic Area

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nullam in dui mauris, at tempus urna. Sed quis ligula id orci varius lobortis.


oncology-1 ONCOLOGY

ONCOLOGY

Oncology Clinical Development ubiquitously uses biomarkers in clinical trials for a range of intended uses. These biomarkers span a range of technologies, require different levels of validation, and ultimately, biomarker data supports submission and approval for the therapeutic. IQVIA Laboratories, with its vast array of validated assays, is able to support most of these requirements across its global testing laboratory network. Of particular relevance for oncology, IQVIA Laboratories provides quick turnaround biomarker data to support patient selection for clinical trials and enable targeted investigational therapeutics to be provided to patients. Underpinned by our wide-ranging oncology clinical trial lab expertise, proven methodologies and cutting-edge technologies, IQVIA Laboratories can effectively support end-to-end oncology-specific testing and assessment needs across Phase I, II and III studies through our global lab network, including:

 

  • Providing key laboratory data for solid tumor, leukemia, lymphoma and multiple myeloma studies worldwide
  • Gaining insights on pharmacokinetics/pharmacodynamics, proof of mechanism safety and efficacy and target patient selection
  • Supporting large and small molecule, vaccine, cell and gene therapy and biosimilar programs
  • Enabling precision medicine through Companion Diagnostics development and related assay validation via CAP and CLIA to ensure use in clinical decision making
  • Providing services for investigational use only studies to work toward in vitro diagnostic registration through seamless and long-standing partnerships with leading IVD companies

 

IQVIA Laboratories provides assay validation services per intended use and is equipped with a comprehensive assortment of assays that are already validated and ready for clinical trial testing. The principal technologies served are IHC and FISH, genomics, flow cytometry, and circulating protein biomarkers.

GI and endo-1 GI & HEPATOLOGY

GI & HEPATOLOGY

At IQVIA Laboratories, we understand that gastro-intestinal and hepato-biliary disorders often require multi-disciplinary approaches to help successfully navigate related clinical trial lab testing and pathology. Our expert pathologists with both GI and liver subspecialty knowledge and extensive clinical care practice can help guide clinical lab testing strategies and anatomic pathology evaluation across key focuses in these disease areas:

 

  • Inflammatory bowel diseases (ulcerative colitis, Crohn’s)
  • Infectious (viral) hepatitis
  • Non-alcoholic fatty liver disease
  • Non-alcoholic steato-hepatitis
  • Neoplastic diseases (hepatocellular and colorectal carcinomas and cholangiocarcinoma)
  • Safety testing for hepato-toxicity
  • Immuno-oncology testing for GI and liver-specific neoplastic diseases

 

Leveraging artificial intelligence-driven enhanced image analysis and next-generation technologies, our expert pathologists can dive deeper into complicated histologic disease patterns and extract meaningful data to help understand disease stage and responses to treatment.

brain CENTRAL NERVOUS SYSTEM

CENTRAL NERVOUS SYSTEM

Supporting a range of CNS indications, our expert team provides global lab testing and assessment capabilities across Phase 1, 2 and 3 studies to support disease identification, inflammation and other intended use needs. Highly specialized in Alzheimer’s disease, the global network allows our team to offer a broad scope of services through the full clinical development program, including:

 

  • Discovery and translational science assay development to support novel assays across blood, serum/plasma and cerebrospinal fluid matrices.

  • Globally harmonized testing, including options in China, through instrumentation such as Quanterix, Simoa, MSD, Luminex, Lumipulse and more.

 

Learn more about Alzheimer’s Disease Clinical Trials here

infectious INFECTIOUS DISEASE

INFECTIOUS DISEASE

As public health needs evolve rapidly, our global lab network of microbiologists highly experienced in infectious disease and vaccine-specific clinical lab testing are equipped to uphold quality standards in practices with agility and scalability. IQVIA Laboratories has extensive services in:

 

  • Bacterial testing from culture and antimicrobial testing to leveraging ELISA technology to detect bacterial antigens and automated processes for bacterial identification, susceptibility and gram staining.
  • Viral testing, specializing in HIV, hepatitis, COVID-19, RSV, influenza and more, we house  many testing modalities, allowing identification via screening assays, resistance testing, sequencing and flow cytometry for immunophenotyping.

 

Quality is a top priority as we keep to standards and guidelines issued by the Clinical and Laboratory Standards Institute and the College of American Pathologists with oversight from experienced scientists and reliance on best-in-class tech-enabled solutions. 

 
immunology IMMUNOLOGY

IMMUNOLOGY

From rheumatoid arthritis to multiple sclerosis to systemic lupus erythematosus, IQVIA Laboratories has vast experience in providing clinical trial lab testing to support a range of immunology conditions. With patient safety and efficacy evaluations key, the expert team supports lab assessments from Phase 1 to Phase 3 studies. Our scope of services, include:

 

  • Discovery and translational science assay development services to support assays and testing technologies used downstream.
  • Cell-mediated immunity testing through flow cytometry, EliSpot assays, peripheral blood mononuclear cell isolation, etc.
  • Humoral immunity assays (i.e., immunoglobulins; complement pathway and a variety of cytokine, chemokine and proinflammatory panels). 
endocrino ENDOCRINOLOGY

ENDOCRINOLOGY

IQVIA Laboratories is equipped with deep therapeutic expertise and transformative solutions to support all phases of clinical development specific to endocrinology. The broad scope of clinical trial lab testing services offered, includes:

 

  • A full suite of testing options for assay validation and clinical trials lab testing across, bioanalytical and protein sciences, delivering critical biomarker assessments.
  • Therapeutic indications include testing for obesity, women’s reproductive health, male infertility, hypothalamus-pituitary-adrenal pathways, thyroid gland indications and large global diabetes programs.
  • Lab assessments for endocrinology Phase 1 through 3 studies for uses such as pharmacokinetics/pharmacodynamics and proof of mechanism safety and efficacy.

 

The expert team can also provide Discovery and Translational Science assay development services to support the new assays and technologies that maybe used downstream.

 
cardio CARDIOVASCULAR

CARDIOVASCULAR

IQVIA Laboratories has available across its global lab footprint a full spectrum of harmonized assays that supports Clinical Trials for Cardiovascular disease. In addition, our parent company IQVIA has an entire suite of Cardiac services including home cardiac monitoring and 30 minute real time review.

  • Lab testing may be broken-down to: 1) Biomarkers of the Risk of Cardiovascular Disease; 2) Biomarkers of active Disease/Damage including myocardial infarction (MI), atrial fibrillation, congestive heart failure (CHF) and 3) Biomarkers of cardiac recovery
  • IQVIA Laboratories offers testing for each of these important areas of cardiac disease:
    • For Risk IQVIA Laboratories offers:
      • Full Lipid Panel: Total cholesterol, HDL, LDL, VLDL, LDL particle number, Lp(a), Lp-PLA2, Apo B, CETP (Cholesteryl Ester Transfer Protein)
      • Inflammatory markers associated with Cardiac Rise: hsCRP, sICAM-1, IL-6, IL-18, SSA, MPO, sCD40
      • Additional serum markers: Oxidized LDL, GPX1 Activity, Nitrotyrosine, Homocysteine, Cystatin-C, Natriuretic peptides (BNP, pro-NT-BNP), ADMA, MMP-9, TIMP
      • Genetic Markers including SNPs, DNA Arrays
    • For Active Cardiac Disease/Damage:
      • Troponin-I, Troponin-T, BNP, pro-NT-BNP, CK, CK-MB, Myoglobin, Heart Type Fatty Acid-Binding Protein, cardiac myosin-binding protein C, IGF-1, VEGF (Vascular endothelial growth factor), MMPs (Matrix Metalloproteinases)
    • For Recovery:
      • DAMP (danger-associated molecular pattern) markers: S100A1 and S100A8, Fibronectin, IL-1α, HSP-60 and HSP-70, NF-κB
respiratory RESPIRATORY (NON-INFECTIOUS)

RESPIRATORY (NON-INFECTIOUS)

IQVIA Laboratories has available across its global lab footprint a full spectrum of harmonized assays that supports Clinical Trials for Respiratory Disease.

  • IQVIA Laboratories has testing procedures for many of the most severe pulmonary diseases, including:
    • Idiopathic Pulmonary Fibrosis – autoimmune testing, CRP, metalloproteinase (MMP)–7, surfactant protein D (SPD), chemokine ligand (CCL)–18, and Krebs von den Lungen-6 for the purpose of distinguishing IPF from other pulmonary diseases may be useful. In addition, with our IQVIA colleagues centralized review of spirometry, radiographic imaging, and pulmonary function studies
    • Cystic Fibrosis – classic sweet chloride testing, and molecular analysis.
    • Non-specific interstitial pneumonia (NSIP) - Connective tissue disease testing for systemic sclerosis, polymyositis/dermatomyositis, rheumatoid arthritis, and Sjogren syndrome. Hypersensitivity pneumonitis testing and testing for IgG4-related systemic disease.
    • Long COVID – Factor testing of C3, C5a, Bb, IL-6, IL-8, TNF-alpha, and the Terminal Complement Complex (TCC).
    • IQVIA Laboratories also supports studies on: Pulmonary Sarcoidosis, Cryptogenic Organizing Pneumonia, Chronic Obstructive Pulmonary Disease, Acute interstitial pneumonia and Lung Cancer
nephro NEPHROLOGY

NEPHROLOGY

IQVIA Laboratories in conjunction with our IQVIA Renal Center for Excellence has designed a full array of globally harmonized assays in support of various of kidney diseases, including: acute kidney, disease (AKD) and chronic kidney disease (CKD), Polycystic Kidney Disease Alport Syndrome, Cystinosis, Fabry’s Disease, APOL1- related nephropathy, Diabetic nephropathy, just to list a few. Our Doctors and Scientists are at the forefront of knowledge in renal disease and have presented “white papers,” in this area.

 

https://labs.iqvia.com/insights/insight-brief-renal-function-clinical-trials


https://www.q2labsolutions.com/blog/the-genesis-of-the-estimated-glomerular-filtration-rate-egfr

 

  • IQVIA Laboratories employs state of the art assays and procedures to support clinical trial investigations in any of these areas. These include:
    • Common Safety testing (CBC and differential and coagulation PT/INR aPTT)
    • Urinalysis, both macroscopic and microscopic
    • Determination of GFR  by numerous methods: including eGFR using the CKD-EPI 2021 calculations and makes available numerous other eGFR such as the Schwartz Bedside for pediatrics; with and without the addition of cystatin-C. . 24 hour urine collection for a measured GFR.
    • Other markers include: β-trace protein (BTP); Neutrophil gelatinase-associated lipocalin (NGAL); Kidney injury molecule 1 (KIM-1); Liver-type fatty acid–binding protein (L-FABP); Asymmetric dimethylarginine (ADMA); Uromodulin; MicroRNA.
    • Genetic analysis is available at our Genomics Laboratory
hemato HEMATOLOGY (NON-CANCER)

HEMATOLOGY (NON-CANCER)

IQVIA Laboratories has available across its global lab footprint a full spectrum of harmonized assays that supports Clinical Trials for Hematological Diseases. (For Cancer Hematological disease, please refer to the Oncology section).

  • Lab Testing for Anemia, Hemophilia and other clotting disorders.
    • Safety testing (CBC and differential)
    • Hemoglobinopathy 
      • Extensive capabilities and expert analysis with consultative capacities
        • Capillary electrophoresis screening
        • HPLC for complex hemoglobulin variants
        • Expert interpretations use electrophoresis/HPLC in context to red cell morphology and indices to provide a complete picture.
        • Molecular genotyping for Hemoglobin A and Hemoglobin B variants is available.Hemoglobinopathy
    • Coagulation (intrinsic and extrinsic pathway analysis deficiencies and inhibitors)
      • Our Coagulation experts guide sponsors and investigators through the complexities of coagulation test from the intricacies of specimen collection through the complex interpretation of results.
      • Assays include
        • Safety assays including PT, aPTT, TCT.
        • Factor assays including Fr VIII and Fr IX
        • Factor inhibition assays by clotting and Nijmegan Modified Bethesda procedures
        • Molecular analysis of various factor mutations
    • Use of Flow cytometry for identification of fetal cells by presence of fetal hemoglobin rather than the insensitive Kleihauer Betke procedure

The experts and expertise you need where you need it

Paramount to our commitment to improving patient outcomes is our extensive global lab network, which allows us to address your specific requirements in each therapeutic area of interest. We achieve this through various aspects of study delivery and logistics. We excel in global kit production and logistics, skillfully navigating changes through our robust supply chain infrastructure, flexible kitting solutions, and agile logistics support. Our clinical study delivery and logistics processes are designed to ensure seamless execution, incorporating a comprehensive governance model that encompasses change management protocols, metrics, KPIs, trend analyses, and risk management plans.

 

Throughout the development lifecycle, our central laboratory customers rely on us for short-term specimen storage and transportation, precisely meeting study requirements through scheduled and unscheduled shipments. As part of our biorepository and specimen management solutions, we consider global logistics management as a key component to successful service delivery.

 

Our dedication to these areas is focused on optimizing patient outcomes because a life depends on every sample we come in contact with. Together, we can turn hope into the help they need.

3214_Scientific Research Team With Clear Solution in Lab

Related Services

card-3212_Close-up shot of microscope with metal lens at laboratory

Anatomic Pathology Laboratory Services

Learn more
card-3229_test tubes for testing

Bioanalytical Services

Learn more
card-3211_Scientist wearing safety glasses

ADME / DMPK Services

Learn more
card-3223_Nurse standing in a laboratory and taking test tubes with blood samples

Biomarker Services

Learn more
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate

Biotech Laboratory Solutions

Learn more
Website Featured_JPG-3842_Scientist working in the Laboratory

Central Laboratory Services

Learn more
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate

Clinical Genomics Laboratory Services

Learn more
card-3270_young woman scientist in laboratory working

Companion Diagnostics (CDx)

Learn more
card-3254_team of doctors working with vaccine research

COVID-19 Clinical Trial Solutions

Learn more
card-3234_Liquid drop from pipette to test tube

Flow Cytometry Assay Development

Learn more
card-3216_Biochemistry expert scientific with eyeglasses

Translational Science and Innovations Laboratory Services (TSAIL)

Learn more
card-3276_A medical scientist is preparing a pathological specimen for diagnosis

Vaccine Laboratory Services

Learn more